NCT05656885

Clinical Evaluation of Two Frequent Replacement Soft Spherical Contact Lenses

Completed NA Results posted Last updated 27 December 2023

What this trial tests

NA trial testing Lens A in Myopia in 40 participants. Completed in 18 October 2022.

Timeline

27 September 2022

Primary endpoint
18 October 2022

18 October 2022

Quick facts

Lead sponsor	CooperVision, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	40
Start date	27 September 2022
Primary completion	18 October 2022
Estimated completion	18 October 2022
Sites	1 location across Spain

Drugs / interventions tested

• Lens A
• Lens B

Conditions studied

• Myopia — all drugs for Myopia →
• Hyperopia — all drugs for Hyperopia →

Sponsor

CooperVision, Inc.

Who can join

18 and older, any sex, with Myopia or Hyperopia. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Lens Fit Acceptance Rating Primary · 15 minutes

Measured on lens fit alone on a scale of 0-4 (0=Should not be used; 1=Limit, but unacceptable; 2=Minimum acceptable, early review; 3=Not perfect, but OK to dispense; 4=Perfect) as assessed by an investigator.

Group	Value	95% CI
Lens A	3.28	± 0.60
Lens B	3.48	± 0.60

Sponsor's own description

This was a single-blind (participant masked), interventional, prospective, direct refit, bilateral wear short-term fitting study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.